Stock screener

DYN

Conviction 39HealthcareScan · Thu, Sep 24, 2026

Dyne Therapeutics, Inc. (DYN) closed at $16.52 (+1.76%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 23, RS Rating 68, -38.3% from its 52-week high, -10.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

DYN$16.52+1.76%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
3
7
7
3
3
3
Vol MA14 4.46M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Dyne Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.dyne-tx.com ↗
Price16.52
Change+1.76%
Gap-0.71%
Rel volume1.60×
Avg volume3.64M
Avg $ vol70.97M
SMA 2020.40
SMA 5023.42
SMA 20019.73
Price vs 50-29.49%
Price vs 200-16.29%
MA stackmixed
50/200 cross—
Supertrenddown · 19.58
RSI (14)23
MACD hist-0.32
MACD cross—
Stoch %K / %D7 / 4
ADX (14)45
+DI / −DI8 / 45
RSI divergence—
MACD divergence—
ATR %6.88%
ADR %5.18%
52w high26.78
52w low12.37
From 52w high-38.33%
Above 52w low+33.51%
New 52w highNo
SqueezeOff
Bollinger width70.62%
%B0.23
Donchian pos5.45%
Donchian high26.49
Donchian low15.94
AVWAP (52w high)20.70
vs AVWAP high-20.21%
AVWAP (52w low)19.58
vs AVWAP low-15.67%
OBV trendDown
Chaikin MF (20)-0.04
Today vs 20d1.60×
Avg vol (14d)4.46M
Avg vol (20d)3.64M
Avg $ vol (20d)70.97M
Market cap3.08B
RS Rating68 / 99
RS 3m (vs SPY)-24.36%
RS 6m (vs SPY)-29.80%
RS line new highNo
Trend template4/8
Technical rank14.5
1 week-8.55%
1 month-37.30%
3 months-19.87%
6 months-12.99%
1 year+25.21%
YTD-10.73%
P/E-6.91
P/B4.39
P/S—
P/FCF-7.61
EPS-3.47
Div yield—
ROE-63.55%
ROA-44.89%
Debt/Eq0.01
Current12.02
EV/EBITDA-5.19
Gross margin—
Net margin—
Rev growth—
EPS growth-40.58%
Price target37.23
Target upside125.43%
Analyst ratingBuy
Institutional115.89%
Ent. value2.42B
Revenue—
Net income-178.56M
Gross profit—
Free cash flow-405.13M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out165.31M
Employees258
ListedThu, Sep 17, 2020
Free float148.8M
Float %90.1%
Short interest20.79M
Days to cover13.5d
Short volume69.0%
Squeeze score81 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.08 vs −$0.74
Last surprise-46.0% miss
Setup gradeD
Conviction39 / 100
Pattern quality—
Tech rank14.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance27.20
Support20.79
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in DYN

All disclosures →
No recent disclosed trades by Congress in DYN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DYN · open-market 10 sells

InsiderSideShares
Rhodes Jason P
Director · Common Stock · 2026-08-14
Sell1.36M
Rhodes Jason P
Director · Common Stock · 2026-08-14
Sell478.38K
Rhodes Jason P
Director · Common Stock · 2026-08-14
Sell322.46K
Rhodes Jason P
Director · Common Stock · 2026-08-13
Sell63.64K
Lucera Erick
Chief Financial Officer · Common Stock · 2026-08-13
Sell1.8K
Kerr Douglas
Chief Medical Officer · Common Stock · 2026-08-13
Sell1.56K
Cox John
CEO & President · Common Stock · 2026-08-13
Sell4.99K
Friedl-Naderer Johanna
Chief Commercial Officer · Common Stock · 2026-08-13
Sell226
Rhodes Jason P
Director · Common Stock · 2026-08-13
Sell268.35K
Rhodes Jason P
Director · Common Stock · 2026-08-13
Sell94.42K

SEC filings

EDGAR filings in DYN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.